EUVIMEDEUVIMED entdecken
Crossref

The role of NADPH oxidase in diabetic kidney disease: Mechanisms, isoforms, and therapeutic opportunities

Shilna Muttickal Swaminathan, Shankar Prasad Nagaraju, Mohan V Bhojaraja, Indu Ramachandra Rao, Ravindra Prabhu Attur, Dharshan Rangaswamy, Srinivas Vinayak Shenoy, Ankur Gupta, Kirthinath Ballala, Sindhura Lakshmi Koulmane Laxminarayana

Journal of Applied Pharmaceutical Science · 2026-03 · 16 (3) · 092-104

DOI: 10.7324/japs.2026.270714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Pharmaceutical Science, online erschienen am 01.03.2026. Verfasst von Shilna Muttickal Swaminathan und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic kidney disease (DKD) is a long-term complication of diabetes mellitus that significantly contributes to morbidity and mortality.In the multifactorial pathogenesis of DKD, NADPH oxidase (Nox) has recently been identified as a pivotal player in both the initiation and progression of disease.Nox enzymes are key producers of reactive oxygen species, perpetuating oxidative stress, which serves as a major trigger for renal cell injury.Thus, it is imperative to assess the precise role of Nox-mediated oxidative stress and the distinct Nox isoforms involved in DKD.Our review provides insights into the intricate mechanisms through which Nox and its subtypes contribute to the pathogenesis of DKD, emphasizing its involvement in glomerular (podocyte, mesangial, and endothelial) and tubular injury, as well as subsequent interstitial inflammation and fibrosis.In addition, we have summarized emerging therapeutic strategies targeting Nox inhibition to mitigate the progression of DKD, which offer focused clinical interventions for improved patient outcomes.

Zitieren

APA

Swaminathan, S. M., Nagaraju, S. P., Bhojaraja, M. V., Rao, I. R., Attur, R. P., Rangaswamy, D., Shenoy, S. V., Gupta, A., Ballala, K., & Laxminarayana, S. L. K. (2026). The role of NADPH oxidase in diabetic kidney disease: Mechanisms, isoforms, and therapeutic opportunities. Journal of Applied Pharmaceutical Science, 16(3), 092-104. https://doi.org/10.7324/japs.2026.270714

Vancouver

Swaminathan SM, Nagaraju SP, Bhojaraja MV, Rao IR, Attur RP, Rangaswamy D, et al. The role of NADPH oxidase in diabetic kidney disease: Mechanisms, isoforms, and therapeutic opportunities. Journal of Applied Pharmaceutical Science. 2026;16(3):092-104. doi:10.7324/japs.2026.270714

BibTeX
@article{Swaminathan2026,
  author = {Swaminathan, Shilna Muttickal and Nagaraju, Shankar Prasad and Bhojaraja, Mohan V and Rao, Indu Ramachandra and Attur, Ravindra Prabhu and Rangaswamy, Dharshan and Shenoy, Srinivas Vinayak and Gupta, Ankur and Ballala, Kirthinath and Laxminarayana, Sindhura Lakshmi Koulmane},
  title = {The role of NADPH oxidase in diabetic kidney disease: Mechanisms, isoforms, and therapeutic opportunities},
  journal = {Journal of Applied Pharmaceutical Science},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {092--104},
  doi = {10.7324/japs.2026.270714}
}
Kostenlos starten →